KORU MEDICAL SYSTEMS, INC.: 10-Q filed 2012-07-16
What KORU MEDICAL SYSTEMS, INC. reported in its quarterly report filed 2012-07-16 (fiscal Q1 2012): 35 published measures, 70 facts as tagged in accession 0001161697-12-000552.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-07-16
- Fiscal period
- fiscal Q1 2012
- Accession
- 0001161697-12-000552 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All KORU MEDICAL SYSTEMS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 4,805,120 | USD | |
| At 2012-02-29 | 4,805,145 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 1,164,053 | USD | |
| At 2012-02-29 | 1,254,417 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 3,641,067 | USD | |
| At 2012-02-29 | 3,550,728 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 1,727,378 | USD | |
| At 2012-02-29 | 1,757,223 | USD | |
| At 2011-05-31 | 1,627,406 | USD | |
| At 2011-02-28 | 1,322,250 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 90,339 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 197,959 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 102,806 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 346,619 | USD | 92 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 121,896 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 31,460 | USD | 92 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | -10,627 | USD | 92 |
| 2011-03-01 to 2011-05-31 | -10,003 | USD | 92 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | -122,024 | USD | 92 |
| 2011-03-01 to 2011-05-31 | -31,460 | USD | 92 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 145,106 | USD | |
| At 2012-02-29 | 54,767 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 35,196,667 | shares | 92 |
| 2011-03-01 to 2011-05-31 | 36,577,667 | shares | 92 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 35,287,576 | shares | 92 |
| 2011-03-01 to 2011-05-31 | 37,327,204 | shares | 92 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-03-01 to 2011-05-31 | 0.01 | USD/shares | 92 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-03-01 to 2011-05-31 | 0.01 | USD/shares | 92 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 47,296 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 141,259 | USD | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 581,395 | USD | |
| At 2012-02-29 | 498,940 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 146,121 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 331,961 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 4,169,340 | USD | |
| At 2012-02-29 | 4,253,536 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 7,207 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 8,076 | USD | 92 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 485,400 | USD | |
| At 2012-02-29 | 558,853 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 226,649 | USD | |
| At 2012-02-29 | 199,527 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 736,990 | USD | |
| At 2012-02-29 | 884,727 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 1,317,444 | USD | |
| At 2012-02-29 | 1,167,456 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 881,770 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 586,778 | USD | 92 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 38,375 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 12,727 | USD | 92 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 35,196,667 | shares | |
| At 2012-02-29 | 35,196,667 | shares |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 23,417 | USD | |
| At 2012-02-29 | 24,513 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 54,385 | USD | |
| At 2012-02-29 | 52,669 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-05-31 | 119,417 | USD | |
| At 2012-02-29 | 153,800 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 137,635 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 339,218 | USD | 92 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 40,537 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 22,319 | USD | 92 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | -8,486 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 7,257 | USD | 92 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | -147,737 | USD | 92 |
| 2011-03-01 to 2011-05-31 | -101,711 | USD | 92 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 149,988 | USD | 92 |
| 2011-03-01 to 2011-05-31 | 161,954 | USD | 92 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-03-01 to 2012-05-31 | 27,122 | USD | 92 |
| 2011-03-01 to 2011-05-31 | -26,483 | USD | 92 |
Inspect the source
- Entity
- KORU MEDICAL SYSTEMS, INC. / CIK 0000704440
- Captured
- 2026-09-19T14:58:00.731Z
- SEC response SHA-256
b53967f6fe0da17327c3bbc894c28ecf420f6c43e7707a871a63a9c303887166
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000704440.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))